The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Digital Edition Archives Authors Reviewers

Page 5

More JCP Articles

JCP
Forty Years at the PTSD Frontier with Barbara O. Rothbaum, PhD
Podcast

Forty Years at the PTSD Frontier with Barbara O. Rothbaum, PhD

June 2, 2026

Barbara O. Rothbaum, PhD, on PTSD treatment: prolonged exposure, MDMA-assisted therapy with PE, VR exposure therapy, and why SSRIs fall short.
,
JCP
Prevalence of GLP-1 Receptor Agonist Use Among Privately Insured Individuals with Mood Disorders
Brief Report

Prevalence of GLP-1 Receptor Agonist Use Among Privately Insured Individuals with Mood Disorders

June 1, 2026

High fill rates of GLP-1 receptor agonist prescriptions in those with mood disorders could indicate that multimorbidity begets more treatment.
, , , et al
JCP
Viloxazine ER in Adults With ADHD and Depression and/or Anxiety Symptoms
Original Research

Viloxazine ER in Adults With ADHD and Depression and/or Anxiety Symptoms

May 27, 2026

Viloxazine ER was well tolerated and associated with improvements in ADHD, depression, and anxiety symptoms in this real-world study.
, , , et al
JCP
National Trends in PTSD among US Military Veterans
Original Research

National Trends in PTSD among US Military Veterans

May 25, 2026

Compared with 2019–2020, past-month PTSD prevalence was higher among men, White and racial/ethnic minority veterans, and veterans aged 18–59 years
, , , et al
JCP
Insomnia, Sleep, and the Use of Sedative-Hypnotic Drugs: Practical Notes
Clinical and Practical Psychopharmacology

Insomnia, Sleep, and the Use of Sedative-Hypnotic Drugs: Practical Notes

May 25, 2026

This article offers practical suggestions related to prescribing sedative-hypnotic drugs, including clinical pearls clinicians need to know.
JCP
Effect of a Nationwide Aftercare Program for Self-Harm Presentations on the Risk of Self-Harm Repetition and Suicide
Original Research

Effect of a Nationwide Aftercare Program for Self-Harm Presentations on the Risk of Self-Harm Repetition and Suicide

May 20, 2026

Aftercare following self-harm was associated with increased risk of repeat self-harm hospital presentation and decreased risk of suicide.
, , , et al
JCP
Differential Impact of Cholecystokinin and Ghrelin on 2-Year Avoidant/Restrictive Food Intake Disorder Symptoms
Original Research

Differential Impact of Cholecystokinin and Ghrelin on 2-Year Avoidant/Restrictive Food Intake Disorder Symptoms

May 20, 2026

Decreases in CCK and increases in ghrelin were associated with improvements in ARFID symptomology.
, , , et al
JCP
Rethinking Postpartum Depression: Biology, Biomarkers, and New Treatments with Jennifer L. Payne, MD
Podcast

Rethinking Postpartum Depression: Biology, Biomarkers, and New Treatments with Jennifer L. Payne, MD

May 19, 2026

Jennifer L. Payne, MD, discusses postpartum depression biomarkers, allopregnanolone and GABA-A receptor biology, and the clinical profile of zuranolone.
,
JCP
NNT, NNH, and LLH for Aripiprazole Once-Monthly in Schizophrenia
Original Research

NNT, NNH, and LLH for Aripiprazole Once-Monthly in Schizophrenia

May 13, 2026

Data demonstrate a favorable benefit-risk profile for aripiprazole once-monthly 400 vs placebo in acute and maintenance treatment of schizophrenia.
, , , et al
JCP
Efficacy and Safety of a Single Dose of Psilocybin for Chronic Suicidal Ideation
Original Research ▶ Video

Efficacy and Safety of a Single Dose of Psilocybin for Chronic Suicidal Ideation

May 13, 2026

A single psilocybin dose with psychological support was associated with rapid, large, and durable reductions in suicidal ideation and depressive symptoms.
, , , et al
JCP
Effects of Experimental Intermittent Theta Burst Stimulation on Negative Symptoms of Schizophrenia
Original Research

Effects of Experimental Intermittent Theta Burst Stimulation on Negative Symptoms of Schizophrenia

May 11, 2026

Findings suggest limited efficacy of experimental intermittent theta burst stimulation over the left DLPFC for negative symptoms.
, , , et al
JCP
Catching Cognitive Decline Early with Gary W. Small, MD
Podcast

Catching Cognitive Decline Early with Gary W. Small, MD

May 5, 2026

Dr. Gary W. Small on the continuum of age-related cognitive decline: biomarkers, differential diagnosis, treatment sequencing, and lifestyle interventions for brain health.
,

Insightful. Evidence-based. Human-centered.

Listen Now
Psychiatrist Steven Berkowitz, MD, discusses psychedelic medicine for trauma treatment

Subscribe to read
more articles

Subscribe